Chewable tablet
OTC drug

Mensil

product website

Composition

Each tablet contains 25 mg of sildenafil in the form of citrate.

Indications

MENSIL is indicated in adult men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
In order for MENSIL to be effective, sexual stimulation is required.

Contraindications

Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway, sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form is therefore contraindicated.

The co-administration of PDE5 inhibitors, including sildenafil, with guanylate cyclase
stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension.

Agents for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure).

MENSIL MAX is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure.

The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated: severe hepatic impairment, hypotension (blood pressure <90/50 mmHg), recent history of stroke or myocardial infarction and known hereditary degenerative retinal disorders such as retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases). The use of sildenafil in these patients is contraindicated.
Hypersensitivity to the active substance or to any of the excipients listed below.

List of excipients:
Potassium polycriline
Anhydrous colloidal silica
Lactose monohydrate
Povidone K-30
Aspartame (E951)
Croscarmellose sodium
Mint flavour: maltodextrin, peppermint oil, sodium starch octenyl succinate (E 1450)
Magnesium stearate
Potassium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)

This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.

Drug information

phone: (+48) 22 742 00 22
informacjaoleku@hasco-lek.pl
Chewable tablet
OTC drug

Mensil

product website

This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.

Drug information

phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl

Composition

Each tablet contains 25 mg of sildenafil in the form of citrate.

Indications

MENSIL is indicated in adult men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
In order for MENSIL to be effective, sexual stimulation is required.

Contraindications

Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway, sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form is therefore contraindicated.

The co-administration of PDE5 inhibitors, including sildenafil, with guanylate cyclase
stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension.

Agents for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure).

MENSIL MAX is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure.

The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated: severe hepatic impairment, hypotension (blood pressure <90/50 mmHg), recent history of stroke or myocardial infarction and known hereditary degenerative retinal disorders such as retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases). The use of sildenafil in these patients is contraindicated.
Hypersensitivity to the active substance or to any of the excipients listed below.

List of excipients:
Potassium polycriline
Anhydrous colloidal silica
Lactose monohydrate
Povidone K-30
Aspartame (E951)
Croscarmellose sodium
Mint flavour: maltodextrin, peppermint oil, sodium starch octenyl succinate (E 1450)
Magnesium stearate
Potassium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)